CytoAgents, Inc., a clinical-stage biotechnology company developing a safe and effective preventative treatment for cytokine release syndrome (CRS) and the neurotoxicity immune effector ...
Winn Chatham, MD (Professor, Clinical Immunology and Rheumatology) and pediatrics colleague Dr. Randy Cron are testing a treatment to halt the potentially fatal immune over-reaction known as cytokine ...
Findings suggest bispecific CD3xCD20 therapy may offer an option for patients with Richter syndrome who are ineligible for transplant or CAR T-cell Therapy. A recent case report published in Cancer ...
INCHEON, South Korea, Aug. 6, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback